Maris-Tech Receives Repeat Order for Approximately $957,000 from a Company in the Defense Industry for its Unique Situational Awareness Solution for Armored Vehicles
June 10, 2024 08:10 ET
|
Maris-Tech Ltd.
This marks the third repeat order from the defense industry customer for this solution, which enables armored fighting vehicle (“AFV”) crews to detect and respond to dismounted threats Total...
Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference
June 10, 2024 08:00 ET
|
Intra-Cellular Therapies Inc.
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central...
Baker Hughes Awarded Major Integrated Solutions Contract for Petrobras’ Offshore Fields
June 10, 2024 08:00 ET
|
Baker Hughes
Multi-year project will see Baker Hughes provide solutions in pre-salt and post-salt fields offshore BrazilBaker Hughes’ comprehensive, integrated approach focuses on operational excellence,...
MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from both FDA and EMA on Path for the Phase 3 Program for the Nanobody® sonelokimab in Psoriatic Arthritis
June 10, 2024 08:00 ET
|
MoonLake Immunotherapeutics AG
MoonLake Immunotherapeutics Announces Positive Regulatory Feedback from both FDA and EMA on Path for the Phase 3 Program for the Nanobody® sonelokimab in Psoriatic Arthritis Builds upon the positive...
AgriFORCE Granted New U.S. Patent for Developmental Automated Growing Systems
June 10, 2024 08:00 ET
|
AgriFORCE Growing Systems Ltd.
VANCOUVER, British Columbia, June 10, 2024 (GLOBE NEWSWIRE) -- AgriFORCE Growing Systems Ltd. (“the Company”) (NASDAQ: AGRI; AGRIW), an intellectual property (IP) focused AgTech company, announces...
Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual Meeting
June 10, 2024 08:00 ET
|
Monopar Therapeutics Inc.
WILMETTE, Ill., June 10, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer...
Sagimet Biosciences to Host Conference Call and Webcast to Discuss Recently Presented Data from ITT and F3 Patient Population in Phase 2b FASCINATE-2 Clinical Trial of Denifanstat
June 10, 2024 08:00 ET
|
Sagimet Biosciences Inc.
SAN MATEO, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN)...
Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366
June 10, 2024 08:00 ET
|
Assembly Biosciences, Inc.
– Phase 1a study portion of single ascending dosing in healthy participants will inform the development of ABI-5366 with interim data expected in Q3 2024 – – Phase 1b study portion of multiple...
LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024
June 10, 2024 08:00 ET
|
LENZ Therapeutics, Inc.
Capstone data from Phase 3 CLARITY study to be presented Event to feature Key Opinion Leader and Principal Investigator perspectives on LNZ100 potential in presbyopia SAN DIEGO, June 10, 2024 ...
Pineapple Energy Announces 1-for-15 Reverse Stock Split Effective June 12, 2024
June 10, 2024 08:00 ET
|
Pineapple Energy
Pineapple Energy Announces Reverse Stock Split Effective June 12, 2024